Trials / Completed
CompletedNCT00211432
Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Manhattan Eye, Ear & Throat Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide compassionate use of anecortave acetate sterile suspension of 15 mg for a series of five patients as a means to control pseudovitelliform detachment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anecortave Acetate Sterile Suspension (15 mg) |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2005-09-21
- Last updated
- 2012-10-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00211432. Inclusion in this directory is not an endorsement.